This module will help you determine appropriate changes to treatment following the withdrawal of rosiglitazone for people with Type 2 Diabetes who are currently taking this medication. The module contains a number of cases giving examples of particular drugs within each class which may or may not be available for prescription in certain areas in the UK or may require particular local funding arrangements. This module is intended to be educational and not an explicit guide for prescribing.
By the end of this module, you will have a better understanding of:
Back
